Advanced colorectal cancer (part 1)
Clinical trials for Advanced colorectal cancer (part 1) explained in plain language.
Never miss a new study
Get alerted when new Advanced colorectal cancer (part 1) trials appear
Sign up with your email to follow new studies for Advanced colorectal cancer (part 1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for Hard-to-Treat cancers with BRAF mutation
Disease control OngoingThis early-stage trial is testing a new oral drug, PF-07799933, in people aged 16 and older with advanced solid tumors that have a specific BRAF gene change. The drug is given alone or combined with other medicines like binimetinib or cetuximab. The study aims to find safe doses …
Matched conditions: ADVANCED COLORECTAL CANCER (PART 1)
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat colorectal tumors
Disease control By invitation onlyThis clinical trial is testing whether combining two drugs—capecitabine (a chemotherapy pill) and lenvatinib (a targeted therapy)—can shrink tumors in people with advanced colorectal cancer that has stopped responding to standard treatments. The study enrolls adults aged 19 and o…
Matched conditions: ADVANCED COLORECTAL CANCER (PART 1)
Phase 1/2 • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC